GB1219606A
(en)
|
1968-07-15 |
1971-01-20 |
Rech S Et D Applic Scient Soge |
Quinuclidinol derivatives and preparation thereof
|
GB8334494D0
(en)
|
1983-12-24 |
1984-02-01 |
Tanabe Seiyaku Co |
Carbostyril derivatives
|
JPS6235216A
(ja)
|
1985-08-09 |
1987-02-16 |
Noritoshi Nakabachi |
不均質物質層の層厚非破壊測定方法および装置
|
GB8916480D0
(en)
|
1989-07-19 |
1989-09-06 |
Glaxo Group Ltd |
Chemical process
|
GB8923590D0
(en)
|
1989-10-19 |
1989-12-06 |
Pfizer Ltd |
Antimuscarinic bronchodilators
|
PT100441A
(pt)
|
1991-05-02 |
1993-09-30 |
Smithkline Beecham Corp |
Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
|
US5451700A
(en)
|
1991-06-11 |
1995-09-19 |
Ciba-Geigy Corporation |
Amidino compounds, their manufacture and methods of treatment
|
WO1993018007A1
(fr)
|
1992-03-13 |
1993-09-16 |
Tokyo Tanabe Company Limited |
Nouveau derive de carbostyrile
|
WO1993019749A1
(fr)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Composes destines a traiter les maladies allergiques et inflammatoires
|
JP3192424B2
(ja)
|
1992-04-02 |
2001-07-30 |
スミスクライン・ビーチャム・コーポレイション |
アレルギーまたは炎症疾患の治療用化合物
|
WO1993019751A1
(fr)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Composes utilisables dans le traitement des maladies inflammatoires et dans l'inhibition de la production du facteur de necrose tumorale
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
GB9414208D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
GB9414193D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
TW528755B
(en)
|
1996-12-24 |
2003-04-21 |
Glaxo Group Ltd |
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
|
WO1999016766A1
(fr)
|
1997-10-01 |
1999-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de benzodioxole
|
GB9723590D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
GB9723566D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
GB9723589D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
YU44900A
(sh)
|
1998-01-31 |
2003-01-31 |
Glaxo Group Limited |
Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
|
PE20000270A1
(es)
|
1998-02-14 |
2000-05-20 |
Glaxo Group Ltd |
Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol
|
US6541669B1
(en)
|
1998-06-08 |
2003-04-01 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
GB9813540D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813535D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813565D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
ID29609A
(id)
|
1998-06-23 |
2001-09-06 |
Glaxo Group Ltd |
Turunan 2-(purin-9-il)-tetrahidrofuran-3,4-diol
|
DE69827673T2
(de)
|
1998-06-30 |
2005-04-21 |
Dow Global Technologies Inc |
Polymerpolyole und ein verfahren zu ihrer darstellung
|
CA2347512C
(fr)
|
1998-10-16 |
2005-12-06 |
Pfizer Inc. |
Derives d'adenine
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
YU25500A
(sh)
|
1999-05-11 |
2003-08-29 |
Pfizer Products Inc. |
Postupak za sintezu analoga nukleozida
|
US6683115B2
(en)
|
1999-06-02 |
2004-01-27 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
GB9913932D0
(en)
|
1999-06-15 |
1999-08-18 |
Pfizer Ltd |
Purine derivatives
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
IL147688A0
(en)
|
1999-08-21 |
2002-08-14 |
Byk Gulden Lomberg Chem Fab |
Synergistic combination
|
CO5180581A1
(es)
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
GB9924363D0
(en)
|
1999-10-14 |
1999-12-15 |
Pfizer Central Res |
Purine derivatives
|
GB9924361D0
(en)
|
1999-10-14 |
1999-12-15 |
Pfizer Ltd |
Purine derivatives
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
GB0003960D0
(en)
|
2000-02-18 |
2000-04-12 |
Pfizer Ltd |
Purine derivatives
|
CA2405745A1
(fr)
|
2000-04-27 |
2001-11-08 |
Boehringer Ingelheim Pharma Kg |
Nouveaux beta-mimetiques a action longue duree, leurs procedes de production et_leur utilisation comme medicament
|
TWI227240B
(en)
|
2000-06-06 |
2005-02-01 |
Pfizer |
2-aminocarbonyl-9H-purine derivatives
|
AU6610001A
(en)
|
2000-06-27 |
2002-01-08 |
S A L V A T Lab Sa |
Carbamates derived from arylalkylamines
|
GB0015727D0
(en)
|
2000-06-27 |
2000-08-16 |
Pfizer Ltd |
Purine derivatives
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
JP2002114788A
(ja)
*
|
2000-08-03 |
2002-04-16 |
Banyu Pharmaceut Co Ltd |
カルバペネム誘導体の製造方法及び合成中間体
|
NZ523958A
(en)
|
2000-08-05 |
2004-11-26 |
Glaxo Group Ltd |
17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derviative as anti-inflammatory agents
|
GB0022695D0
(en)
|
2000-09-15 |
2000-11-01 |
Pfizer Ltd |
Purine Derivatives
|
GB0028383D0
(en)
|
2000-11-21 |
2001-01-03 |
Novartis Ag |
Organic compounds
|
KR100869722B1
(ko)
|
2000-12-22 |
2008-11-21 |
알미랄 에이쥐 |
퀴누클리딘 카르바메이트 유도체 및 m3 길항제로서 그의사용
|
HUP0303524A3
(en)
|
2000-12-28 |
2008-03-28 |
Almirall Ag |
Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same and their use
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
WO2002070490A1
(fr)
|
2001-03-08 |
2002-09-12 |
Glaxo Group Limited |
Agonistes de beta-adrenocepteurs
|
EP1241176A1
(fr)
|
2001-03-16 |
2002-09-18 |
Pfizer Products Inc. |
Dérivés de purine pour le traitement de l'ischémie
|
EP1370521B1
(fr)
|
2001-03-22 |
2007-12-19 |
Glaxo Group Limited |
Derives formanilides utilises en tant qu'agonistes de l'adrenorecepteur beta2
|
MY137522A
(en)
|
2001-04-30 |
2009-02-27 |
Glaxo Group Ltd |
Novel anti-inflammatory androstane derivatives.
|
PA8546101A1
(es)
|
2001-05-25 |
2003-12-10 |
Pfizer |
Un antagonista de a2a en combinacion con un agente anticolinergico para el tratamiento de enfermedades obstructivas de las vias aereas
|
ES2307751T3
(es)
|
2001-06-12 |
2008-12-01 |
Glaxo Group Limited |
Nuevos esteres heterociclicos centi-inflamatorios 17 alfa de derivados 17 beta de carbotioato de androstano.
|
CA2445046C
(fr)
|
2001-06-21 |
2009-11-24 |
Diversa Corporation |
Nitrilases
|
USRE44874E1
(en)
|
2001-09-14 |
2014-04-29 |
Glaxo Group Limited |
Phenethanolamine derivatives for treatment of respiratory diseases
|
WO2003033495A1
(fr)
|
2001-10-17 |
2003-04-24 |
Ucb, S.A. |
Derives de quinuclidine, leurs procedes de preparation, et leurs utilisations en tant qu'inhibiteurs de recepteur muscarinique m2 et/ou m3
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
MY130622A
(en)
|
2001-11-05 |
2007-07-31 |
Novartis Ag |
Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
|
PL370207A1
(en)
|
2001-11-09 |
2005-05-16 |
Cv Therapeutics, Inc. |
A2b adenosine receptor antagonists
|
WO2003042160A1
(fr)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Agonistes de recepteur d'aryl aniline beta-2 adrenergique
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
AU2002356759A1
(en)
|
2001-12-01 |
2003-06-17 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
JP4505227B2
(ja)
|
2001-12-20 |
2010-07-21 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
1−アルキル−1−アゾニアビシクロ[2.2.2]オクタンカルバメート誘導体およびムスカリンレセプターアンタゴニストとしてのそれらの使用
|
AU2003202044A1
(en)
|
2002-01-15 |
2003-09-09 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
WO2003062259A2
(fr)
|
2002-01-21 |
2003-07-31 |
Glaxo Group Limited |
Nouveaux composes
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
WO2004078163A2
(fr)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Compositions pharmaceutiques a base d'un co-cristal
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
EP1490317A1
(fr)
|
2002-03-26 |
2004-12-29 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Mimetiques du glucocorticoide, procedes de fabrication de ces mimetiques, compositions pharmaceutiques et leurs utilisations
|
EA008830B1
(ru)
|
2002-03-26 |
2007-08-31 |
Бёрингер Ингельхайм Фармасьютиклз, Инк. |
Миметики глюкокортикоидов, способы их получения, фармацевтические композиции и их применение
|
US20090170803A1
(en)
|
2002-04-10 |
2009-07-02 |
Linden Joel M |
Adjunctive treatment of biological diseases
|
EP1496892B1
(fr)
|
2002-04-11 |
2011-01-26 |
Merck Sharp & Dohme Corp. |
Derives de 1h-benzo(f)indazol-5-yl utilises en tant que modulateurs selectifs du recepteur glucocorticoide
|
ES2206021B1
(es)
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
JP2005523920A
(ja)
|
2002-04-25 |
2005-08-11 |
グラクソ グループ リミテッド |
フェネタノールアミン誘導体
|
WO2003099764A1
(fr)
|
2002-05-28 |
2003-12-04 |
Theravance, Inc. |
Agonistes du recepteur adrenergique $g(b)2 alcoxy aryle
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
ES2201907B1
(es)
|
2002-05-29 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
|
DE10224888A1
(de)
|
2002-06-05 |
2003-12-24 |
Merck Patent Gmbh |
Pyridazinderivate
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10225574A1
(de)
|
2002-06-10 |
2003-12-18 |
Merck Patent Gmbh |
Aryloxime
|
DE10227269A1
(de)
|
2002-06-19 |
2004-01-08 |
Merck Patent Gmbh |
Thiazolderivate
|
AU2003243870B2
(en)
|
2002-06-25 |
2008-11-20 |
Merck Frosst Canada Ltd |
8-(biaryl) quinoline PDE4 inhibitors
|
WO2004005258A1
(fr)
|
2002-07-02 |
2004-01-15 |
Merck Frosst Canada & Co. |
Ethane pyridone a substitution diaryle, inhibiteurs d'enzyme pde4
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
JP4503436B2
(ja)
|
2002-07-08 |
2010-07-14 |
ファイザー・プロダクツ・インク |
糖質コルチコイド受容体のモジュレーター
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
AR040962A1
(es)
|
2002-08-09 |
2005-04-27 |
Novartis Ag |
Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
|
EP1556369A1
(fr)
|
2002-08-10 |
2005-07-27 |
ALTANA Pharma AG |
Derives de pyridazinone utilises comme inhibiteurs de pde4
|
AU2003255376A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-derivatives as pde4 inhibitors
|
US20060094710A1
(en)
|
2002-08-10 |
2006-05-04 |
Altana Pharma Ag |
Piperidine-pyridazones and phthalazones as pde4 inhibitors
|
CA2494643A1
(fr)
|
2002-08-10 |
2004-03-04 |
Altana Pharma Ag |
Derives de n-oxyde de piperidine
|
PL374014A1
(en)
|
2002-08-17 |
2005-09-19 |
Altana Pharma Ag |
Novel phenanthridines having pde 3/4 inhibiting properties
|
RS20050117A
(en)
|
2002-08-17 |
2007-06-04 |
Altana Pharma Ag., |
Novel benzonaphthyridines
|
ATE403648T1
(de)
|
2002-08-21 |
2008-08-15 |
Boehringer Ingelheim Pharma |
Substituierte dihydrochinoline als glucocorticoid-mmimetika,verfahren zu deren herstellung, pharmazeutische zubereitungen und deren verwendung
|
CN1688544A
(zh)
|
2002-08-23 |
2005-10-26 |
兰贝克赛实验室有限公司 |
作为蕈毒碱受体拮抗剂的含氟代和磺酰氨基的3,6-二取代的氮杂双环(3.1.0)己烷衍生物
|
BR0313923A
(pt)
|
2002-08-29 |
2005-07-12 |
Boehringer Ingelheim Pharma |
Derivados de 3-(sulfonamidoetil)-indol para uso como miméticos de glicocorticóide no tratamento de doenças inflamatórias, alérgicas e proliferativas
|
WO2004019944A1
(fr)
|
2002-08-29 |
2004-03-11 |
Altana Pharma Ag |
2-hydroxy-6-phenylphenanthridines utilisees comme inhibiteurs de pde-4
|
US7423046B2
(en)
|
2002-08-29 |
2008-09-09 |
Nycomed Gmbh |
3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
JP2006096662A
(ja)
|
2002-09-18 |
2006-04-13 |
Sumitomo Pharmaceut Co Ltd |
新規6−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
JP4520309B2
(ja)
|
2002-09-20 |
2010-08-04 |
メルク・シャープ・エンド・ドーム・コーポレイション |
選択的糖質コルチコイド受容体調節剤としてのオクタヒドロ−2−H−ナフト[1,2−f]インドール−4−カルボキサミド誘導体
|
JP2004107299A
(ja)
|
2002-09-20 |
2004-04-08 |
Japan Energy Corp |
新規1−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
DE10246374A1
(de)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
EP1440966A1
(fr)
|
2003-01-10 |
2004-07-28 |
Pfizer Limited |
Dérivés d'indole utilisables pour traiter des maladies
|
KR20050047552A
(ko)
|
2002-10-11 |
2005-05-20 |
화이자 인코포레이티드 |
베타-2 작용제로서의 인돌 유도체
|
JP2006506373A
(ja)
|
2002-10-22 |
2006-02-23 |
グラクソ グループ リミテッド |
医薬アリールエタノールアミン化合物
|
CN100532374C
(zh)
|
2002-10-23 |
2009-08-26 |
格兰马克药品有限公司 |
可用于治疗炎性和变应性病症的新的三环化合物:它们的制备方法以及包含它们的药物组合物
|
WO2004037773A1
(fr)
|
2002-10-28 |
2004-05-06 |
Glaxo Group Limited |
Derive de phenethanolamine utilise dans le traitement de maladies respiratoires
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225287D0
(en)
|
2002-10-30 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10253220A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
DE10253282A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
DE10253426B4
(de)
|
2002-11-15 |
2005-09-22 |
Elbion Ag |
Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
|
DE10261874A1
(de)
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
PL378245A1
(pl)
|
2003-01-09 |
2006-03-20 |
Astellas Pharma Inc. |
Pochodne pirolopirydazyny
|
US7732432B2
(en)
|
2003-01-21 |
2010-06-08 |
Merck Sharp & Dohme Corp. |
17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
EP1460064A1
(fr)
|
2003-03-14 |
2004-09-22 |
Pfizer Limited |
Derivés de Indole-2-carboxamide comme beta-2 agonistes
|
US7317102B2
(en)
|
2003-04-01 |
2008-01-08 |
Theravance, Inc. |
Diarylmethyl and related compounds
|
PT1613315E
(pt)
|
2003-04-04 |
2009-04-22 |
Novartis Ag |
Derivados da quinolina-2-ona para o tratamento de doenças das vias aéreas respiratórias
|
AR044134A1
(es)
|
2003-05-02 |
2005-08-24 |
Novartis Ag |
Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
|
EP1477167A1
(fr)
|
2003-05-15 |
2004-11-17 |
Pfizer Limited |
Dérivés de [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl come agonistes de beta2
|
US7268147B2
(en)
|
2003-05-15 |
2007-09-11 |
Pfizer Inc |
Compounds useful for the treatment of diseases
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
EP1626970B1
(fr)
|
2003-05-28 |
2009-07-08 |
Theravance, Inc. |
Composes d'azabicycloalcane utilises en tant qu'antagonistes des recepteurs muscariniques
|
ATE384697T1
(de)
|
2003-06-04 |
2008-02-15 |
Pfizer |
2-amino-pyridin-derivate als beta-2 adrenoreceptor agonisten
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
US7439260B2
(en)
|
2003-06-11 |
2008-10-21 |
Merck Forsst Canada & Co. |
7-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
|
WO2004111044A1
(fr)
|
2003-06-17 |
2004-12-23 |
Glenmark Pharmaceuticals Ltd. |
Composes tricycliques efficaces dans le traitement des affections inflammatoires et allergiques : leur procede de preparation
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
ITMI20031451A1
(it)
|
2003-07-16 |
2005-01-17 |
Zambon Spa |
Derivati diidro-ftalazinici inibitori della fosfodiesterasi 4
|
EP1658270A1
(fr)
|
2003-07-31 |
2006-05-24 |
ALTANA Pharma AG |
Nouvelles 6-phenylphenanthridines
|
WO2005012253A1
(fr)
|
2003-07-31 |
2005-02-10 |
Altana Pharma Ag |
Nouvelles 6-phenylphenanthridines
|
PT1664026E
(pt)
*
|
2003-08-15 |
2009-04-23 |
Merck & Co Inc |
Inibidores de cinesina mitótica
|
GB0322726D0
(en)
|
2003-09-27 |
2003-10-29 |
Glaxo Group Ltd |
Compounds
|
GB0322722D0
(en)
|
2003-09-27 |
2003-10-29 |
Glaxo Group Ltd |
Compounds
|
WO2005033121A2
(fr)
|
2003-10-03 |
2005-04-14 |
King Pharmaceuticals Research & Development, Inc. |
Synthese de 2-aralkyloxyadenosines, 2-alkoxyadenosines, et leurs analogues
|
GB0323701D0
(en)
|
2003-10-09 |
2003-11-12 |
Glaxo Group Ltd |
Formulations
|
GB0324654D0
(en)
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
US8025794B2
(en)
|
2003-12-19 |
2011-09-27 |
Shell Oil Company |
Systems, methods, and catalysts for producing a crude product
|
JP2005187357A
(ja)
|
2003-12-25 |
2005-07-14 |
Nippon Suisan Kaisha Ltd |
選択的なβ2受容体アゴニスト活性を有するベンゾチアゾロン誘導体の製造方法
|
DE102004001413A1
(de)
|
2004-01-09 |
2005-08-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
3-Hydroxymethyl-4-Hydroxy-Phenyl-Derivate zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
TW200531692A
(en)
|
2004-01-12 |
2005-10-01 |
Theravance Inc |
Aryl aniline derivatives as β2 adrenergic receptor agonists
|
ES2289691T3
(es)
|
2004-01-22 |
2008-02-01 |
Pfizer, Inc. |
Derivados de sulfonamida para el tratamiento de enfermedades.
|
ATE375977T1
(de)
|
2004-01-22 |
2007-11-15 |
Pfizer |
Sulfonamidderivate zur behandlung von krankheiten
|
DE102004003428A1
(de)
|
2004-01-23 |
2005-08-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
|
GB0402797D0
(en)
|
2004-02-09 |
2004-03-10 |
Novartis Ag |
Organic compounds
|
US7320990B2
(en)
|
2004-02-13 |
2008-01-22 |
Theravance, Inc. |
Crystalline form of a biphenyl compound
|
JP4916317B2
(ja)
|
2004-02-14 |
2012-04-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規持続作用性β−2−アゴニスト及び薬剤としてのその使用
|
JP2007527900A
(ja)
|
2004-03-10 |
2007-10-04 |
アルタナ ファルマ アクチエンゲゼルシャフト |
チオ含有の新規のヒドロキシ−6−フェニルフェナントリジン及びpde4インヒビターとしてのそれらの使用
|
NZ549254A
(en)
|
2004-03-10 |
2010-06-25 |
Nycomed Gmbh |
Amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
|
EP1574501A1
(fr)
|
2004-03-11 |
2005-09-14 |
Pfizer Limited |
Dérivés de quinoléinone, compositions pharmaceutiques les contenant et leur usage
|
CA2560098A1
(fr)
|
2004-03-15 |
2005-09-22 |
Kyowa Hakko Kogyo Co., Ltd. |
Derive de 2-aminoquinazoline
|
US7244728B2
(en)
|
2004-03-17 |
2007-07-17 |
Boehringer Ingelheim International Gmbh |
Long acting betamimetics for the treatment of respiratory diseases
|
US7671068B2
(en)
|
2004-03-17 |
2010-03-02 |
Nycomed Gmbh |
N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors
|
EP1577292A1
(fr)
|
2004-03-17 |
2005-09-21 |
Pfizer Limited |
Dérivées de phenylaminoethanol comme agonistes des recepteurs beta2
|
CA2559203A1
(fr)
|
2004-03-17 |
2005-09-29 |
Pfizer Inc. |
Composes convenant pour le traitement de maladies
|
US20050215542A1
(en)
|
2004-03-23 |
2005-09-29 |
Pfizer Inc |
Compounds for the treatment of diseases
|
BRPI0507877A
(pt)
|
2004-03-23 |
2007-07-24 |
Pfizer |
derivados de formamida, composição farmacêutica, uso dos mesmos e combinação
|
WO2005092860A1
(fr)
|
2004-03-23 |
2005-10-06 |
Pfizer Limited |
Composes servant au traitement de maladies
|
AU2005225638A1
(en)
|
2004-03-23 |
2005-10-06 |
Pfizer Inc. |
Compounds for the treatment of diseases
|
AU2005227733A1
(en)
|
2004-04-02 |
2005-10-13 |
Glaxo Group Limited |
Chemical process and new crystalline form
|
DE102004019539A1
(de)
|
2004-04-22 |
2005-11-10 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
|
US20050239778A1
(en)
|
2004-04-22 |
2005-10-27 |
Boehringer Ingelheim International Gmbh |
Novel medicament combinations for the treatment of respiratory diseases
|
US7307076B2
(en)
|
2004-05-13 |
2007-12-11 |
Boehringer Ingelheim International Gmbh |
Beta agonists for the treatment of respiratory diseases
|
US20050256115A1
(en)
|
2004-05-14 |
2005-11-17 |
Boehringer Ingelheim International Gmbh |
Aerosol formulation for the inhalation of beta-agonists
|
US7745621B2
(en)
|
2004-05-14 |
2010-06-29 |
Boehringer Ingelheim International Gmbh |
Long acting bronchodilators for the treatment of respiratory diseases
|
PE20060426A1
(es)
*
|
2004-06-02 |
2006-06-28 |
Schering Corp |
DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
|
CA2569395A1
(fr)
|
2004-06-03 |
2005-12-22 |
Theravance, Inc. |
Agonistes des recepteurs .beta.2 adrenergiques diaminiques
|
JP2008507532A
(ja)
|
2004-07-21 |
2008-03-13 |
セラヴァンス, インコーポレーテッド |
ジアリールエーテルβ2アドレナリン作用性レセプターアゴニスト
|
GB0416397D0
(en)
|
2004-07-22 |
2004-08-25 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
WO2006023460A2
(fr)
|
2004-08-16 |
2006-03-02 |
Theravance, Inc. |
Composes a activite agoniste pour recepteur ?2 adrenergique et antagoniste pour recepteur muscarinique
|
US7838597B2
(en)
|
2004-08-20 |
2010-11-23 |
Sekisui Specialty Chemicals America, Llc |
Fluid loss concentrate for hydraulic cement
|
WO2006031556A2
(fr)
|
2004-09-10 |
2006-03-23 |
Theravance. Inc. |
Composes d'arylaniline a substitution amidine
|
GB0424284D0
(en)
|
2004-11-02 |
2004-12-01 |
Novartis Ag |
Organic compounds
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
MX2007008459A
(es)
|
2005-01-11 |
2007-07-25 |
Glaxo Group Ltd |
Sales de cinamato de un agonista beta-2 adrenergico.
|
SI1891038T1
(sl)
*
|
2005-05-13 |
2009-04-30 |
Lilly Co Eli |
Substituirani n-arilpirolodini kot selektivni modulatorji androgenskega receptorja
|
PL2206707T3
(pl)
*
|
2007-10-24 |
2015-01-30 |
Astellas Pharma Inc |
Związek azolokarboksamidowy lub jego sól
|
KR101324804B1
(ko)
|
2008-05-13 |
2013-11-01 |
아이알엠 엘엘씨 |
키나제 억제제로서의 질소 함유 융합 헤테로사이클 및 그의 조성물
|
ES2612731T3
(es)
*
|
2008-08-19 |
2017-05-18 |
Janssen Pharmaceutica Nv |
Antagonistas de receptores al frío de mentol
|
ES2588504T3
(es)
*
|
2008-10-22 |
2016-11-03 |
Array Biopharma, Inc. |
Compuestos de pirazolo[1,5-a]pirimidina sustituidos como compuestos intermedios en la síntesis de inhibidores de TRK quinasa
|
TW201022233A
(en)
*
|
2008-11-04 |
2010-06-16 |
Organon Nv |
(Pyrrolidin-2-yl)phenyl derivatives
|
US8927545B2
(en)
*
|
2009-03-30 |
2015-01-06 |
Duke University |
Inhibiting Eph B-3 kinase
|
AR077468A1
(es)
*
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
US8637516B2
(en)
*
|
2010-09-09 |
2014-01-28 |
Irm Llc |
Compounds and compositions as TRK inhibitors
|